LABT insider transactions
Lakewood-Amedex Biotherapeutics Inc. (LABT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
LABT insiders
Everyone who has filed a Form 3, 4, 5 or 144 at Lakewood-Amedex Biotherapeutics Inc., latest first. Follow anyone to get their next filing.
- Joseph Edward TuckerDirector, since April 2026
- Leonard James DeRomaDirector, since April 2026
- Thomas BalzerChief Medical Officer, since April 2026
- Kelvin CooperChief Executive Officer, Director, since April 2026
- Peter CeccacciChief Financial Officer, since April 2026
Recent Form 3, 4, and 5 filings for LABT
- SEC Form 4 filed by Director Tucker Joseph Edward4 - Lakewood-Amedex Biotherapeutics Inc. (0002079272) (Issuer)
- New insider Tucker Joseph Edward claimed no ownership of stock in the company (SEC Form 3)3 - Lakewood-Amedex Biotherapeutics Inc. (0002079272) (Issuer)
- New insider Deroma Leonard James claimed ownership of 187,736 units of Common Stock; $0.0001 par value (SEC Form 3)3 - Lakewood-Amedex Biotherapeutics Inc. (0002079272) (Issuer)
- New insider Balzer Thomas claimed ownership of 255,322 units of Common Stock; $0.0001 par value (SEC Form 3)3 - Lakewood-Amedex Biotherapeutics Inc. (0002079272) (Issuer)
- New insider Cooper Kelvin claimed ownership of 300,594 units of Common Stock; $0.0001 par value (SEC Form 3)3 - Lakewood-Amedex Biotherapeutics Inc. (0002079272) (Issuer)
- New insider Ceccacci Peter claimed ownership of 468,148 units of Common Stock; $0.0001 par value (SEC Form 3)3 - Lakewood-Amedex Biotherapeutics Inc. (0002079272) (Issuer)